UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

          Date of Report (Date of earliest event reported) May 2, 2007

                             BSD MEDICAL CORPORATION
             (Exact name of registrant as specified in its charter)

                            Delaware0-1078375-1590407
                 (State or other jurisdiction of incorporation)
                            (Commission File Number)
                          (IRS Employer Identification)

                              2188 West 2200 South
                           Salt Lake City, Utah 84119
          (Address of principal executive offices, including Zip Code)
       Registrant's telephone number, including area code: (801) 972-5555

                                       N/A
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting  material  pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

--------------------------------------------------------------------------------



Item 7.01     Regulation FD Disclosure.
BSD Medical  Corporation  issued a press  release on May 2, 2007.  A copy of the
press release is hereby furnished as Exhibit 99.1 attached hereto.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits 99.1 Press Release of
BSD Medical Corporation dated May 2, 2007


                                   SIGNATURES
         Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated:  May 2, 2007
                                             By:    /s/  Hyrum A. Mead
                                                    ----------------------------
                                                    President



                                  EXHIBIT INDEX
 Exhibit No.    Description
 99.1           Press Release of BSD Medical Corporation dated May 2, 2007